10 citations
,
January 2010 in “Veterinary pathology”
This study found that a newly identified mutation in the hairlessgene in mice led to decreased Hr mRNA levels and changes in gene expression related to hair follicle development.
3 citations
,
March 2016 in “Experimental Dermatology”
This study found that a hypomorphic mutation in the Hr gene contributes to the development of diet-induced pruritic atopic skin in mice, particularly when combined with dietary deficiencies of polyunsaturated fatty acids and starch.
9 citations
,
June 2000 in “Journal of The American Academy of Dermatology”
This study reported that heterozygous carriers of a mutation in the human hairlessgene did not differ from healthy homozygotes in the pattern of androgenetic alopecia.
Dutasteride is more effective than finasteride for increasing hair count, but finasteride is considered safer for long-term use unless hair loss is very aggressive. Starting with finasteride is recommended due to its effectiveness and safety profile.
Prolactin may contribute to hair loss, but targeting its receptor won't cure androgenetic alopecia. ABS-201 could be a useful alternative or adjuvant therapy, similar to JAK inhibitors, but not more effective than HMI-115.
There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.
Hair loss can persist despite using treatments like finasteride, dutasteride, and minoxidil due to factors like genetic sensitivity, incomplete DHT blockage, and other hormonal influences. Individual responses vary, and some may require a combination of treatments to stabilize hair loss.